Related Experiment Videos
The Implementation and One-Year Evaluation of a Pre-Admission Pharmacist for Obstetric Admissions
Bridget Clark1, Nabeelah Mukadam1, Tamara Lebedevs1
1Women and Newborn Health Service, King Edward Memorial Hospital, Subiaco 6008, Australia.
Abstract:
(1) Objective: This study aims to evaluate the pre-admission clinic (PAC) pharmacist for high-risk obstetric patients' admissions on medication management processes, workflow efficiency, and staff satisfaction. (2) Methods: Data collected over a 12-month period, from March 2025 to February 2026, were analysed. Data collected included clinic type, patient attendance, mode of pharmacist review, and follow-up requirements. Multidisciplinary healthcare professionals were invited to complete a satisfaction survey to identify themes relating to service value, workflow impact, and opportunities for improvement. (3) Results: A total of 1039 interviews with obstetric patients, equating to an average of 19.98 interviews per week. A total of 999 patients were involved in the 1039 interviews held, 40/999 (4%) patients required additional follow-up telephone interview and 14 patients (14/999, 1.4%) required in-person interview for interpreter services, detailed discussion or hearing impairment. Thirty-two staff responded to a survey and demonstrated a consistent trend across anaesthetists, nursing and midwifery staff, and pharmacists. All respondents either agreed or strongly agreed that a PAC pharmacist in the obstetric setting was valuable and beneficial to clinical workflow and medication management processes, and that they were satisfied with the PAC pharmacy service. (4) Conclusions: The PAC pharmacist demonstrated a positive impact on medication management for obstetric patients within the pre-admission setting.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimens: Designs and Approaches